CORY MILLER: Open Payments
NPI 1346298510 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 71 payments from 20 companies in 2025. Trend: 2023 $1,384 · 2024 $1,017 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $304 |
| Abbott Laboratories | 3 | $150 |
| Lilly USA, LLC | 16 | $139 |
| Amgen Inc. | 5 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
| Novo Nordisk Inc | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, QULIPTA, VRAYLAR, Kerendia, UBRELVY, VOQUEZNA, JARDIANCE.
Industry payments across UT — which companies pay providers there.
